Chemoinformaics analysis of NNN’N0-Tetra-methylholarrhimine
| Molecular Weight | 102.181 | nRot | 2 |
| Heavy Atom Molecular Weight | 88.069 | nRig | 0 |
| Exact Molecular Weight | 102.116 | nRing | 0 |
| Solubility: LogS | 1.063 | nHRing | 0 |
| Solubility: LogP | 0.026 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 19.8851 |
| nHD | 0 | BPOL | 17.4649 |
| QED | 0.455 |
| Synth | 2.861 |
| Natural Product Likeliness | -0.374 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.011 |
| HIA | 0.005 |
| CACO-2 | -5.315 |
| MDCK | 0.000011 |
| BBB | 0.934 |
| PPB | 0.125311 |
| VDSS | 1.85 |
| FU | 0.902673 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.531 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.943 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.145 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0 |
| CYP3a4-sub | 0.153 |
| CL | 7.165 |
| T12 | 0.442 |
| hERG | 0.026 |
| Ames | 0.017 |
| ROA | 0.902 |
| SkinSen | 0.914 |
| Carcinogencity | 0.104 |
| EI | 0.846 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.964759 |